Abendschein D R, Recchia D, Meng Y Y, Oltrona L, Wickline S A, Eisenberg P R
Department of Internal Medicine, Washington University School of Medicine, Saint Louis, Missouri 63110, USA.
J Am Coll Cardiol. 1996 Dec;28(7):1849-55. doi: 10.1016/S0735-1097(96)00362-2.
We sought to determine whether brief, profound inhibition of thrombin or prothrombin activation by factor Xa limits neointimal formation and stenosis after arterial injury.
Thrombin has been implicated as a mediator of neointimal formation, but adjunctive administration of anticoagulant agents has not proven effective to decrease restenosis in patients undergoing coronary angioplasty.
We infused recombinant desulfatohirudin (r-hirudin, bolus of 2 mg/kg body weight followed by 2 mg/kg per h, n = 9), heparin (100 U/kg per h, n = 6) or recombinant tick anticoagulant peptide (rTAP, 1-mg/kg bolus followed by 3 mg/kg per h, n = 5), a specific inhibitor of factor Xa, intravenously, beginning 15 min before and for up to 3 h after repetitive balloon hyperinflations sufficient to disrupt the internal elastic lamina in a carotid artery of minipigs with hypercholesterolemia induced by feeding them an atherogenic diet.
Partial thromboplastin time was increased six- to sevenfold over baseline levels at the end of the infusions of the anticoagulant agents. Lumen stenosis measured histologically 4 weeks after balloon-induced carotid injury was 29 +/- 16% (mean +/- SEM) in r-hirudin-treated, 52 +/- 19% in rTAP-treated and 76 +/- 18% in heparin-treated pigs (p < 0.02 for r-hirudin vs. heparin treatment).
The marked reduction of stenosis in r-hirudin-treated animals indicates that thrombin plays a major role in neointimal formation after balloon-induced arterial injury. A relatively brief interval of profound, direct inhibition of thrombin may be particularly effective to attenuate restenosis after balloon angioplasty.
我们试图确定短暂、深度抑制凝血酶或凝血酶原被因子Xa激活是否能限制动脉损伤后的内膜增生和狭窄。
凝血酶被认为是内膜增生的介质,但辅助使用抗凝剂在接受冠状动脉成形术的患者中并未被证明能有效减少再狭窄。
我们对高胆固醇血症小型猪喂食致动脉粥样硬化饮食诱导后,通过反复球囊过度扩张足以破坏其颈动脉内弹力层,在扩张前15分钟开始并在其后长达3小时内静脉输注重组去硫酸水蛭素(r-水蛭素,2mg/kg体重推注,随后2mg/kg每小时,n = 9)、肝素(100U/kg每小时,n = 6)或重组蜱抗凝肽(rTAP,1mg/kg推注,随后3mg/kg每小时,n = 5),rTAP是因子Xa的特异性抑制剂。
在输注抗凝剂结束时,部分凝血活酶时间比基线水平增加了6至7倍。球囊诱导颈动脉损伤4周后组织学测量的管腔狭窄在r-水蛭素治疗组为29±16%(平均值±标准误),rTAP治疗组为52±19%,肝素治疗组为76±18%(r-水蛭素与肝素治疗相比,p < 0.02)。
r-水蛭素治疗动物中狭窄的显著降低表明,凝血酶在球囊诱导的动脉损伤后的内膜增生中起主要作用。相对短暂的深度直接抑制凝血酶的时间间隔可能对减轻球囊血管成形术后的再狭窄特别有效。